Gallium-68 Prostate Specific Membrane Antigen PET in Diagnosing Patients With Thyroid Cancer
Status:
Terminated
Trial end date:
2020-10-31
Target enrollment:
Participant gender:
Summary
This pilot clinical trial studies how well Gallium-68 prostate specific membrane antigen
positron emission tomography (PET) work in diagnosing patients with thyroid cancer.
Diagnostic procedures, such as 68Ga-PSMA PET, may more accurately diagnose thyroid cancer and
find out how far the disease has spread.